Stratifying risk of Alzheimer’s disease in healthy middle-aged individuals with machine learning is a research paper published in Brain Communications (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AG070937
National Institutes of Health
Grant: RD004723
National Institutes of Health
Grant: P30 AG066511
National Institutes of Health
Grant: U01AG061357
National Institutes of Health
Grant: R35GM152245
National Science Foundation
Grant: 1944247
Chan Zuckerberg Initiative
Grant: 253558
Alzheimer’s Disease Neuroimaging Initiative
Grant: U01 AG024904
Department of Defense Alzheimer’s Disease Neuroimaging Initiative
Grant: W81XWH-12-2-0012
NIA NIH HHS
Grant: U19 AG065169
Alzheimer's Drug Discovery Foundation
BioClinica, Inc.
Eisai Inc.
Eli Lilly and Company
Johnson & Johnson Pharmaceutical Research & Development LLC.
Neurotrack Technologies
Pfizer Inc.
Servier
Meso Scale Diagnostics, LLC.
National Institute on Aging
Takeda Pharmaceutical Company
EuroImmun
Lundbeck
Northern California Institute for Research and Education
Biogen
Bristol-Myers Squibb Company
Cogstate
Elan Pharmaceuticals, Inc.
Fujirebio
Janssen Alzheimer Immunotherapy Research And Development
National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Association
Araclon Biotech
Canadian Institutes of Health Research
F. Hoffmann-La Roche Ltd
IXICO Ltd
Lumosity
NeuroRx Research
Novartis Pharmaceuticals Corporation
Transition Therapeutics
CereSpir, Inc.
Merck & Co., Inc.
GE Healthcare
Genentech, Inc.
Piramal Imaging
University of Southern California
FWCI
5.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords